[1] 林瑶, 李晓惠, 石琳, 等. 2017年版《川崎病的诊断、治疗及远期管理——美国心脏协会对医疗专业人员的科学声明》解读[J]. 中国实用儿科杂志, 2017, 32(9):641-648. [2] Dietz S M, van Stijn D, Burgner D, et al. Dissecting Kawasaki disease:A state-of-the-art review[J]. European Journal of Pediatrics, 2017, 176(8):995-1009. [3] Basha A, Rawat A, Jindal A K, et al. Autoantibody profile in children with Kawasaki disease on long-term follow-up:A prospective study from North India[J]. International Journal of Rheumatic Diseases, 2018, 21(11):2036-2040. [4] 李婷, 叶盛, 张晨美. 儿童川崎病休克综合征35例分析[J]. 浙江医学, 2022, 44(9):958-964. [5] 赵小佩, 肖婷婷, 张永为. 川崎病休克综合征临床特征分析[J]. 临床儿科杂志, 2019, 37(4):245-249. [6] 杜美娜, 孟瑞荣. 川崎病休克综合征与川崎病临床特征对照分析[J]. 中国现代医学杂志, 2020, 30(9):85-89. [7] Kanegaye J T, Wilder M S, Molkara D, et al. Recognition of a Kawasaki disease shock syndrome[J]. Pediatrics, 2009, 123(5):e783-e789. [8] McCrindle B W, Rowley A H, Newburger J W, et al. Diagnosis, reatment, and long-term management of Kawasaki disease:A scientific statement for health professionals from the American heart association[J]. Circulation, 2017, 135(17):e927-e999. [9] Gámez-González L B, Murata C, Muñoz-Ramírez M, et al. Clinical manifestations associated with Kawasaki disease shock syndrome in Mexican children[J]. European Journal of Pediatrics, 2013, 172(3):337-342. [10] 李锋. 32例川崎病休克综合征患儿的临床特征分析及早期识别危险因素初探[D]. 沈阳:中国医科大学, 2021. [11] Taddio A, Rossi E D, Monasta L, et al. Describing Kawasaki shock syndrome:Results from a retrospective study and literature review[J]. Clinical Rheumatology, 2017, 36(1):223-228. [12] Verma P, Agarwal N, Maheshwari M. Recurrent Kawasaki disease[J]. Indian Pediatrics, 2015, 52(2):152-154. |